인용/피인용
'
리스페리돈이 타액선 세포에 미치는 영향' 의 주제별 논문영향력
| 주제 |
|
|
|---|---|---|
| 동일주제 총논문수 | 논문피인용 총횟수 | 주제별 논문영향력의 평균 |
| 621 | 0 |
0.0% |
주제별 논문영향력
' 리스페리돈이 타액선 세포에 미치는 영향' 의 참고문헌
-
이우주의 약리학강의 5판의학문화사 : 7 ~ 26 [2003]
-
소아정신약물학서울대학교출판부 : 101 ~ 276 [2005]
-
Xerostomia: etiology, recognition and treatmentAm Dent Assoc 134 : 61 ~ 69 [2003]
-
Xerostomia: clinical aspects and treatmentGerodontology 20 : 64 ~ 77 [2003]
-
Treatment of psychosis: 30 years of progressJ Clin Pharm Ther 31 : 523 ~ 534 [2006]
-
Treatment of psychosis in Parkinson’s disease: safety considerationsDrug Saf 26 : 643 ~ 659 [2003]
-
The safety and pharmacokinetics of quetiapine when coadminis tered with haloperidol, risperidone, or thioridazineJ Clin Psychopharmacol 22 : 121 ~ 130 [2002]
-
Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents최상진 [2007]
-
Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease
-
Second-generation antipsychotic medications in children and adolescents정순영 [2004]
-
Salivary symptoms in Parkinson’s disease정미나 [1973]
-
Salivary production in Parkinson’s disease정미경 [2005]
-
Saliva secretion in patients with allergic rhinitis정미경 [2006]
-
Risperidone use in the treatment of behavioral symptoms in children with autism정경아 [2006]
-
Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy정갑영 [2006]
-
Risperidone augmentation of clozapine: a critical review정갑영 [2006]
-
Regulation of calcium in salivary gland secretion임연기 [2000]
-
Reassessment of Fura-2 and the ratio method for determination of intracellular Ca2+ concentrations이희수 [1991]
-
Quetiapine for schizophrenia이한열 [2004]
-
Quantitative study of salivary secretion in Parkinson’s disease이학규 [2006]
-
Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry이채연 [2004]
-
Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable
-
Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004
-
Olanzapine: an updated review of its use in the management of schizophrenia유현옥 [2001]
-
Olanzapine augmentation for treatment-resistant obsessivecompulsive disorder유현숙 [2000]
-
Non-invasive assessment of swallowing and respiration in Parkinson’s disease우한용 [2000]
-
Low unstimulated salivary flow an subjective oral dryness: association with medication, anxiety, depression, and stress
-
Laryngeal deglutition movement in Parkinson’s disease보건복지가족부 [1997]
-
Influence of Parkinson’s disease on oral health박인우 [1992]
-
Hypersalivation induced by olanzapine with fluvoxamine문성애 [2006]
-
First drug to treat irritability associated with autism김진아 [2007]
-
Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia김은란 [2005]
-
Effects of extracellular ATP on ion transport systems and [Ca2+]i in rat parotid acinar cells. Comparison with the muscarinic agonist carbachol김선중 [1990]
-
Drug effects on salivary glands김경희 [2003]
-
Characterization of swallowing and defecation in Parkinson’s diseaseTorp [1994]
-
Binding of antipsychotic drugs to human brain receptors focus on newer generation compoundsSchmidt [2000]
-
Basic and clinical pharmacology 9th editionSabatier [2004]
-
Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinationsPower [2002]
-
A study of salivary secretion in Parkinson’s diseaseManz [1999]
-
A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilitiesLipson [2001]
-
A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone databaseLincoln [2001]
-
A new generation of Ca2+ indicators with greatly improved fluorescence propertiesLazarus [1985]
-
A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study
-
A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviorsKline [2005]